An interventional study of Bovine or Marine Collagen in Skin Laxity, Hair Thinning and Nails, sponsored by Ancient + Brave. Recruiting at 1 site in United Kingdom. Open to female participants aged 35 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Ancient + Brave · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Alopecia with a site in United Kingdom — 2 open to participants now, 2 under way, 1 of them phase 3. Alopecia · United Kingdom.
Among the 11 studies in Alopecia with a site in United Kingdom, this one is the 8th largest by planned enrollment, is the only one that started in 2024, is one of 4 with no phase, and was the 10th registered.
512 studies on the registry are indexed under Alopecia; 129 are open to participants now.
Browse Alopecia studies →2 of the 11 studies in Alopecia with a site in United Kingdom are open now. Recruiting first, the newest first:
Pfizer · Sites in United Kingdom, United States, Canada and 8 more countries
Ages 12+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 75 Alopecia studies recruiting now, 25 (33%) set no upper age limit and 46 (61%) stop at 75 or younger; 9 take children under 18; 24 take healthy volunteers.
This study: 35 Years to 55 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 2 · Phase 3 5
First in 2010; this study’s year is marked. 1 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 90 is above the median of 50 across 431 interventional studies indexed under Alopecia.
Median enrollment 158 across the 11 interventional studies. Of the 7 that completed or were terminated, 4 (57%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 11 have an industry lead sponsor. The 8 most frequent:
This is the only study on the registry with Ancient + Brave as lead sponsor.
Ancient + Brave has 1 study filed under Alopecia — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 11 studies in Alopecia with a site in United Kingdom, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The BECOME Study (Bovine and Marine Collagen Efficacy for Skin, Hair, Nails and Whole Body Health Markers Evaluation) is a randomized controlled trial designed to compare the effects of bovine and marine collagen supplements versus a placebo on skin, hair, nails and whole body health markers. The trial aims to determine the most efficacious collagen source for improving health outcomes and to establish if both types of collagen are equally effective. Participants will be assessed on various health parameters, including skin elasticity, joint health, digestive health, and overall well-being, over a specified period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Females aged 35-55 years. Participants must be comfortable with bovine or marine collagen (non-vegan/vegetarian).
Must provide and be willing to comply with study requirements.
Exclusion Criteria:
Pregnant or breastfeeding women. History of chronic skin conditions (e.g., eczema, psoriasis) that might interfere with study outcomes.
Any active skin infections or severe acne. Currently taking collagen supplements or have taken them within the last 6 months.
Use of medications or topical agents that can affect skin, hair, nails, or gastrointestinal health (e.g., , retinoids).
Excessive alcohol consumption or current smokers. Regular use of sunbeds. Recent cosmetic procedures (e.g., Botox, fillers, chemical peels, laser treatments) on skin, hair, or nails within the last 3 months.
Any condition or situation that, in the opinion of the investigator, may interfere with the participant's ability to comply with the study requirements or give .
Poor adherence to previous study protocols
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
10g powder format taken daily for duration of the study.
Dietary Supplement: Bovine or Marine Collagen
10g powder format taken daily for duration of the study.
Dietary Supplement: Bovine or Marine Collagen
Dietary Supplement: Bovine or Marine Collagen
Bovine or Marine Collagen
Change in nail strength and growth
Assessment of nail strength and growth will be assessed by self-perception questionnaire
Time frame: Baseline, week 6 and week 12
Change in skin elasticity
Changes in skin elasticity will be measured by a cutometer
Time frame: Baseline, week 6 and week 12
Change in hair thickness and strength
Strength and breakage of hair will be assessed by self perception questionnaire
Time frame: Baseline, week 6 and week 12
Change in skin wrinkles
Measurement of the reduction in skin wrinkles using Profilometer
Time frame: Baseline, week 6 and week 12
Change in perceived skin health
Changes in perceived skin health assessed by self perception questionnaire
Time frame: Baseline, week 6 and week 12
Change in skin wrinkles by visual assessment
Change in skin wrinkles will be performed by visual assessment by a dermatologist
Time frame: Baseline, week 6 and week 12
Changes in skin pigmentation
Changes in skin pigmentation will be assessed by Chromameter
Time frame: Baseline, week 6 and week 12
Changes in skin hydration
Changes in skin hydration will be assessed by a Corneometer
Time frame: Baseline, week 6 and week 12
Digestive Quality of Life (DQDL) Assessment
Participants will complete a Digestive Quality of Life (DQDL) Assessment to evaluate the digestive health benefits
Time frame: Baseline, week 6 and week 12
Subjective Perception Questionnaire
Subjective Perception Questionnaire (SPQ) for Whole Body Health to capture participants\' self-reported perceptions of their overall health and well-being
Time frame: Baseline, week 6 and week 12
Plan to share: Undecided
No publications or documents are linked to this record.
Started Aug 2024 (actual). Primary completion is estimated for Nov 2024, 2 months after the start.
Of 61 industry-sponsored interventional studies with no phase under Alopecia, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 20. This study's planned 2 months is below that.
Counting every sponsor, half of 146 studies reached it within 12 months; a quarter within 6 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.